Deciphering TP53 Mosaic Variants on Germline Biomarker Testing: Implications for Oncology Nurses
Germline biomarker testing of the TP53 gene can produce confusing results including mosaicism or clonal hematopoiesis of indeterminate potential (CHIP). When noninformative results are reported, additional testing is usually.
Authors
- Suzanne M. Mahon (ORCID: https://orcid.org/0000-0003-0919-6444)
- Alyssa A Grissom
Institutions
- Swisstom (Switzerland) (CH)
- State University of Zanzibar (TZ)
Publication Details
- Journal
- Clinical journal of oncology nursing
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1188/25.cjon.201-206
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00